[go: up one dir, main page]

MX2010008875A - Agonistas nicotinicos alfa 7 y antipsicoticos. - Google Patents

Agonistas nicotinicos alfa 7 y antipsicoticos.

Info

Publication number
MX2010008875A
MX2010008875A MX2010008875A MX2010008875A MX2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A MX 2010008875 A MX2010008875 A MX 2010008875A
Authority
MX
Mexico
Prior art keywords
combination
antipsychotics
alpha
nicotinic agonists
nicotinic
Prior art date
Application number
MX2010008875A
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Kristen G Jordan
Terry Hauser
Sharon R Letchworth
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Publication of MX2010008875A publication Critical patent/MX2010008875A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una combinación sinergística de un agonista nicotínico alfa7 (a7) y un agente antipsicótico.
MX2010008875A 2008-02-13 2009-02-13 Agonistas nicotinicos alfa 7 y antipsicoticos. MX2010008875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
PCT/US2009/034062 WO2009102962A2 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics

Publications (1)

Publication Number Publication Date
MX2010008875A true MX2010008875A (es) 2010-08-31

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008875A MX2010008875A (es) 2008-02-13 2009-02-13 Agonistas nicotinicos alfa 7 y antipsicoticos.

Country Status (25)

Country Link
US (1) US20110059947A1 (es)
EP (2) EP2633868A1 (es)
JP (1) JP2011511845A (es)
KR (1) KR20100113163A (es)
CN (2) CN101977628A (es)
AU (1) AU2009214625A1 (es)
BR (1) BRPI0907570A2 (es)
CA (1) CA2715268A1 (es)
CO (1) CO6290706A2 (es)
CY (1) CY1114492T1 (es)
DK (1) DK2254598T3 (es)
EC (1) ECSP10010471A (es)
ES (1) ES2430622T3 (es)
HR (1) HRP20130749T1 (es)
IL (1) IL207389A0 (es)
MX (1) MX2010008875A (es)
NZ (1) NZ587312A (es)
PL (1) PL2254598T3 (es)
PT (1) PT2254598E (es)
RS (1) RS52941B (es)
RU (1) RU2481123C2 (es)
SG (1) SG188144A1 (es)
SI (1) SI2254598T1 (es)
WO (1) WO2009102962A2 (es)
ZA (1) ZA201005999B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
CN106074548A (zh) 2010-09-23 2016-11-09 艾伯维巴哈马有限公司 氮杂金刚烷衍生物的一水合物
SG191986A1 (en) * 2011-01-18 2013-08-30 Targacept Inc Treatment of cognitive dysfunction in schizophrenia
WO2012151136A1 (en) * 2011-05-03 2012-11-08 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
KR20150064098A (ko) * 2012-10-02 2015-06-10 다이닛본 스미토모 세이야꾸 가부시끼가이샤 이미다졸 유도체
JP6807094B2 (ja) * 2016-04-29 2021-01-06 国立大学法人秋田大学 クロザピン又はその誘導体の血中薬剤濃度上昇リスク判定方法及び薬剤投与量判定方法
CN110087641B (zh) 2016-12-20 2024-03-12 罗曼治疗系统股份公司 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统
MX382195B (es) 2016-12-20 2025-03-13 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗系统股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
US12329862B2 (en) 2018-06-20 2025-06-17 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
PL3810100T3 (pl) 2018-06-20 2025-05-12 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
CN117529475A (zh) 2021-01-08 2024-02-06 艾福姆德尤股份有限公司 用于治疗与sting活性有关的疾病的含脲或类似物的杂双环化合物及其化合物
EP4274660A1 (en) * 2021-01-08 2023-11-15 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
ATE255888T1 (de) 1998-06-01 2003-12-15 Ortho Mcneil Pharm Inc Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
EA005002B1 (ru) * 1999-12-10 2004-10-28 Уайт НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-e]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ
DK1300407T4 (da) 2000-06-27 2011-09-05 S A L V A T Lab Sa Carbamater afledt af arylalkylaminer
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016356A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
JP2004506734A (ja) 2000-08-21 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用のキヌクリド置換ヘテロアリール部分
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
HUP0303529A3 (en) 2000-12-22 2008-03-28 Almirall Ag New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
CA2476624A1 (en) * 2002-02-19 2003-08-28 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
HRP20050494A2 (en) * 2002-12-06 2005-10-31 Pharmacia & Upjohn Company Llc Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
EP1699488A2 (en) * 2003-12-23 2006-09-13 Pfizer Products Incorporated Therapeutic combination for cognition enhancement and psychotic disorders
WO2006101745A2 (en) * 2005-03-18 2006-09-28 Abbott Laboratories Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions

Also Published As

Publication number Publication date
KR20100113163A (ko) 2010-10-20
RU2010137787A (ru) 2012-03-20
CA2715268A1 (en) 2009-08-20
CN103143023A (zh) 2013-06-12
PT2254598E (pt) 2013-10-16
EP2254598B1 (en) 2013-07-10
PL2254598T3 (pl) 2013-12-31
CY1114492T1 (el) 2016-10-05
ES2430622T3 (es) 2013-11-21
JP2011511845A (ja) 2011-04-14
IL207389A0 (en) 2010-12-30
WO2009102962A2 (en) 2009-08-20
US20110059947A1 (en) 2011-03-10
AU2009214625A1 (en) 2009-08-20
ZA201005999B (en) 2011-05-25
EP2254598A2 (en) 2010-12-01
RS52941B (sr) 2014-02-28
HRP20130749T1 (en) 2013-10-11
SG188144A1 (en) 2013-03-28
ECSP10010471A (es) 2010-10-30
SI2254598T1 (sl) 2013-10-30
RU2481123C2 (ru) 2013-05-10
DK2254598T3 (da) 2013-07-29
HK1147954A1 (en) 2011-08-26
WO2009102962A3 (en) 2009-10-08
NZ587312A (en) 2011-12-22
CO6290706A2 (es) 2011-06-20
EP2633868A1 (en) 2013-09-04
BRPI0907570A2 (pt) 2019-09-24
CN101977628A (zh) 2011-02-16

Similar Documents

Publication Publication Date Title
MX2010008875A (es) Agonistas nicotinicos alfa 7 y antipsicoticos.
ZA201103044B (en) Conjugates of glp-1 agonists and uses thereof
HRP20130713T1 (en) Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
IL262838A (en) Guanylate cyclase agonists for use in the treatment of hypercholesterolemia
PL2252671T3 (pl) Podobna do azeotropu kompozycja 1,1,1-trifluoro-3-chloropropenu i dimetoksymetanu
IL202510A0 (en) Agonists of guanylate cyclase, compositions comprising the same and uses thereof
TWI372757B (en) Ep2 agonists
SG171584A1 (en) Nanoparticulate metal boride composition and its use for identification- marking plastic parts
TN2011000040A1 (en) Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
MY156511A (en) Compositions and devices
IL193042A0 (en) Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
IL215050A0 (en) Gpr119 agonist compound, compositions comprising the same and uses thereof
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
IL215051A0 (en) Gpr119 agonist compound, compositions comprising the same and uses thereof
ZA201001252B (en) Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
IL212909A0 (en) Anti - wrinkle agents and compositons comprising the same
DK1987121T3 (da) Biocid hydrogenperoxidsammensætning med forøget aktivitet
JO2730B1 (en) Medications for the treatment of endometriosis
IL192485A0 (en) Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
ZA201104160B (en) Crhr2 peptide agonists and uses thereof
ZA200805203B (en) Lubricant composition with improved solvency
ZA200900611B (en) EP2 agonists
UA99332C2 (en) Herbicidal combinations having diflufenican and pinoxaden and use thereof
EP2274326A4 (en) GAMMA INHIBITOR ENDOGENOUS INTERFERONS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal